Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
The Canadian Journal of Cardiology
|
June 28, 2006
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm
David H Fitchett, Bjug Borgundvaag, Warren Cantor, et al.
Journal of the American Heart Association
|
March 23, 2021
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
João Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial
Muthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
Diabetes Research and Clinical Practice
|
March 22, 2022
Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease
Stefan D Anker, Leif-Erik Sander, David H Fitchett, et al.
American Heart Journal
|
September 26, 2006
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes
Raymond T Yan, Andrew T Yan, Mary Tan, et al.
The American Journal of Cardiology
|
May 26, 2009
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes
Alan J Bagnall, Shaun G Goodman, Keith A A Fox, et al.
The American Journal of Medicine
|
August 5, 2006
Contemporary management of dyslipidemia in high-risk patients: targets still not met
Andrew T Yan, Raymond T Yan, Mary Tan, et al.
The Canadian Journal of Cardiology
|
December 7, 2007
Missed opportunities for the secondary prevention of cardiovascular disease in Canada
Daniel G Hackam, Lawrence A Leiter, Andrew T Yan, et al.
The Canadian Journal of Cardiology
|
June 16, 2010
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada
Manoela Braga, Amparo Casanova, Hwee Teoh, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
Subodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
The Canadian Journal of Cardiology
|
June 28, 2006
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm
David H Fitchett, Bjug Borgundvaag, Warren Cantor, et al.
Journal of the American Heart Association
|
March 23, 2021
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
João Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial
Muthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
Diabetes Research and Clinical Practice
|
March 22, 2022
Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease
Stefan D Anker, Leif-Erik Sander, David H Fitchett, et al.
American Heart Journal
|
September 26, 2006
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes
Raymond T Yan, Andrew T Yan, Mary Tan, et al.
The American Journal of Cardiology
|
May 26, 2009
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes
Alan J Bagnall, Shaun G Goodman, Keith A A Fox, et al.
The American Journal of Medicine
|
August 5, 2006
Contemporary management of dyslipidemia in high-risk patients: targets still not met
Andrew T Yan, Raymond T Yan, Mary Tan, et al.
The Canadian Journal of Cardiology
|
December 7, 2007
Missed opportunities for the secondary prevention of cardiovascular disease in Canada
Daniel G Hackam, Lawrence A Leiter, Andrew T Yan, et al.
The Canadian Journal of Cardiology
|
June 16, 2010
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada
Manoela Braga, Amparo Casanova, Hwee Teoh, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
Subodh Verma, Michael E Farkouh, Bobby Yanagawa, et al.
Page
of 6